Hemab Therapeutics

Clinical-stage biotechnology company developing prophylactic antibody therapies for underserved bleeding and thrombotic disorders, including rare conditions beyond hemophilia.

Location
Copenhagen, Denmark
Founded
2020
Investors
1
Categories
biotech, hematology, bleeding-disorders, antibody-therapeutics

Investors

NameLocationTypeStagesPortfolio
Sofinnova PartnersParis, Francebiotech-focused
seedseries-a+3
23